Markets:

Overview

News

Currencies

International

Treasuries

CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.620 -0.050 (-1.07%)

Streaming Delayed Price Updated: 3:09 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about CureVac N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth ↗

August 04, 2025

BioNTech beat Q2 estimates with higher COVID vaccine revenue and reaffirmed 2025 guidance.

Via Benzinga

Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma ↗

July 08, 2025

The CDC reportedly deactivated its bird flu emergency response last week, folding surveillance into its regular flu tracking and ending animal infection updates.

Via Stocktwits

This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

June 26, 2025

Via Benzinga

5 Stocks To Ride The German Market Rally ↗

June 16, 2025

Via Benzinga

Insights Ahead: CureVac's Quarterly Earnings ↗

April 09, 2025

Via Benzinga

Why CureVac (CVAC) Stock Is Moving ↗

January 08, 2025

Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday's strong gains driven by rising concerns over U.S. respiratory illnesses.

Via Benzinga

This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday ↗

June 13, 2025

Via Benzinga

Market Monitor News June 13 (Oracle UP - Gamestop DOWN) ↗

June 13, 2025

U.S. stocks edge higher as inflation cools, Oracle soars on AI growth, and markets brace for Israel-Iran conflict escalation.

Via Chartmill

Topics Artificial Intelligence Economy

Here are the top movers in Thursday's session. ↗

June 12, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

June 12, 2025

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results ↗

June 12, 2025

Via Benzinga

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal ↗

June 12, 2025

BioNTech agreed to buy CureVac for $1.25 billion, expanding its mRNA cancer research and boosting its oncology pipeline.

Via Benzinga

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday ↗

June 12, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

June 12, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment ↗

June 12, 2025

Under the terms of the deal, each CureVac share will be exchanged for approximately $5.46 in BioNTech American depositary shares.

Via Stocktwits

Wondering what's happening in today's pre-market session? ↗

June 12, 2025

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Via Chartmill

Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort ↗

May 29, 2025

The Trump administration terminated a nearly $600 million award to Moderna for developing an mRNA-based bird flu vaccine, ending a key Biden-era pandemic preparedness initiative. The cancellation...

Via Benzinga

Topics Government

CureVac (CVAC) Stock Rises After Q1 Update, Oncology Pipeline Gains Traction ↗

May 20, 2025

CureVac stock surged after reporting Q1 2025 results and a positive pipeline update. The biotech firm narrowed its operating loss, and cash is expected to fund operations through 2028.

Via Benzinga

CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode ↗

April 10, 2025

The company reported revenue of €14.5 million for the fourth quarter, representing a decrease of €8.1 million from the corresponding period of 2023, and below an analyst estimate of €20.58, according...

Via Stocktwits

Topics Government

Earnings Scheduled For April 10, 2025 ↗

April 10, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Friday's session. ↗

March 28, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Top movers in Friday's pre-market session ↗

March 28, 2025

The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday ↗

March 28, 2025

Via Benzinga

European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps ↗

March 28, 2025

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in July 2025.

Via Benzinga

Topics Intellectual Property

Wondering what's happening in today's after-hours session? ↗

March 27, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch ↗

February 10, 2025

A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye."

Via Benzinga

Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads ↗

January 24, 2025

As the bird flu virus continues to spread through the United States, the Trump administration on Tuesday ordered all communications from the Centers for Disease Control and Prevention to stop.

Via Benzinga

Topics Government

Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine ↗

January 21, 2025

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of bird flu in the U.S. and one death associated with the virus.

Via Benzinga

Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing ↗

January 16, 2025

The CDC issued a health advisory Thursday recommending that hospitalized patients who have tested positive for influenza be tested for the bird flu virus within 24 hours.

Via Benzinga

Why CureVac (CVAC) Shares Are Volatile ↗

January 10, 2025

CureVac shares have been volatile over the past week, gaining some 25%. The stock has seen increased trading volume following the U.S.'s first human death from H5N1 bird flu.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.